Trinity Biotech announce revenue increase

Trinity Biotech, the developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced a revenue increase of 25% for the third quarter of the year.

In an announcement today it revealed revenues in the quarter increased 25.1% to $26.9m (€22.1m) compared to $21.5m (€17.6m) in the same period last year.